Selection of radionuclides for radioimmunotherapy

Abstract
Selection criteria for radionuclides to be used in radioimmunotherapy are reviewed. Among the topics covered are half‐life, specific activity, type of emission, and ease of preparation. (AIP)
Funding Information
  • U.S. Department of Energy (DE‐AC02‐76CH00016)

This publication has 0 references indexed in Scilit: